intratumoral injection

2 trials

Sponsors

Novartis, Faculty of medicine, Chiang mai University

Conditions

1. Procedure complications 2. Complications due to the steroid useSolid tumors and lymphoma (lymph tissue cancer)

Phase 1

The safety and result of intratumoral steroid injection for aggressive fibromatosis

RecruitingTCTR20150409001

Faculty of medicine, Chiang mai University1. Procedure complications 2. Complications due to the steroid use

Start: 2015-01-01Target: 10Updated: 2026-08-03

Unknown Phase

A Phase Ib, open label, multicenter study of the safety and efficacy of MIW815 (ADU-S100) administered by intratumoral injection with PDR001 to patients with advanced/metastatic solid tumors or lymphomas

Active, not recruitingNL-OMON48864

NovartisSolid tumors and lymphoma (lymph tissue cancer)

Start: 2018-08-16Target: 12Updated: 2024-02-28

Related Papers

Safety and efficacy of intralesional steroid injection for aggressive fibromatosis.

2017-11-022 citations